Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Turcot syndrome 1Lymphatic Metastasis 1

Interventions

Specimen Handling 280Magnetic Resonance Spectroscopy 233pembrolizumab 220Carboplatin 180Cisplatin 146Biopsy 146Cyclophosphamide 138Paclitaxel 128Nivolumab 118Bevacizumab 106Gemcitabine 105Radiotherapy 90Dexamethasone 83Pemetrexed 79fludarabine 74Docetaxel 74atezolizumab 73Fluorouracil 73Doxorubicin 73Radiation 72Leucovorin 68Rituximab 66Oxaliplatin 64venetoclax 60Prednisone 60durvalumab 58Cetuximab 56Vincristine 55Etoposide 54Lenalidomide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
DNA Mismatch Repair × 30 days × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡